1[1]Rizk NP, Chang MY, El Kouri C, et al. The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer. Cancer Gene Ther,1999,6(4)∶291-301.
2[2]Kawabe S, Munshi A, Zumstein LA, et al. Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts. Int J Radiat Biol,2001,77(2)∶185-94.
3[3]Carroll JL, Nielsen LL, Pruett SB, et al. The role of natural killer cells in adenovirus-mediated p53 gene therapy.Mol Cancer Ther,2001,1(1)∶49-60.
4[4]Roth JA, Nguyen D, Lawrence DD, et al. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med,1996,2(9)∶985-991.
5[5]Schuler M, Rochlitz C, Horowitz JA, et al. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Hum Gene Ther,1998,9(14)∶2075-2082.
6[6]Swisher SG, Roth JA, Nemunaitis J, et al. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst,1999,91(9)∶763-771.
7[7]Roth JA, Swisher SG, Merritt JA, et al. Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement. Semin Oncol,1998,25(3 Suppl 8)∶33-37.
8[8]Kubba S, Adak S, Schiller J, et al. Phase 1 trial of adenovirus p53 in bronchioalveolar cell lung carcinoma (BAG) administered by bronchoalveolar lavage. Proc Am Soc Clin Oncol,2000,19(3)∶487a.
9[9]Inoue A, Narumi K, Matsubara N, et al. Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drugs in human lung cancer cells irrespective of the status of p53 gene. Cancer Lett,2000,157(1)∶105-112.
10[10]Nemunaitis J, Swisher SG, Timmons T, et al. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J Clin Oncol,2000,18(3)∶609-622.
10Nemuaitis J, Swisher SG,Timmons T, et al.Adenovirus-mediated p53 gene transfer in sequence with cisplatin totumors of patients with non-small-cell lung cancer [J]. J Clin Oncol, 2000, 18:609-622